Latest News in the pharma Industry

Top Stories

Novartis & SomaLogic Sign Research Deal for Proteomics Technology

Novartis & SomaLogic Sign Research Deal for Proteomics Technology

20 Oct 2011

SomaLogic has signed a multi-year research agreement with Novartis to use its proteomics technology to accelerate Novartis' drug discovery.

Read more 
Veteran's New Target: A Story from Mark Roberts, Founder of Roberts Chemicals

Veteran's New Target: A Story from Mark Roberts, Founder of Roberts Chemicals

19 Oct 2011

A 30-year veteran of the fine chemicals industry has launched his own business, with a new model.

Read more 
Servier & Miragen Ink $352M Partnership Deal

Servier & Miragen Ink $352M Partnership Deal

19 Oct 2011

Under the partnership, the two companies will advance the research, development and commercialization of three drug candidates.

Read more 
Jubilant Biosys & Norgine Enter into Discovery Agreement

Jubilant Biosys & Norgine Enter into Discovery Agreement

19 Oct 2011

Under the agreement, Jubilant will deliver preclinical candidates and Norgine will have rights to further development and commercialization of treatments in the area of gastrointestinal disease.

Read more 
WHO: Widely Available Treatments Keeping Malaria under Better Control

WHO: Widely Available Treatments Keeping Malaria under Better Control

19 Oct 2011

A WHO report says one-third of the 108 countries, where malaria was endemic, were on course to eradicate the disease within ten years.

Read more 
Roche to Acquire Anadys for $230M

Roche to Acquire Anadys for $230M

18 Oct 2011

Roche is to acquire Anadys Pharmaceuticals for $230 million in cash to strenthen its HCV portfolio.

Read more 
ICON Appoints Colin Stanley as DOCS President

ICON Appoints Colin Stanley as DOCS President

18 Oct 2011

ICON has named new president of DOCS, the company's global resourcing division.

Read more 
Janssen & BeiGene Sign for Oncology Compounds

Janssen & BeiGene Sign for Oncology Compounds

17 Oct 2011

The two companies have inked a deal for the clinical development and commercialization of two clinical-stage oncology compounds.

Read more 
WuXi PharmaTech Acquires Abgent for Antibody Reagents

WuXi PharmaTech Acquires Abgent for Antibody Reagents

17 Oct 2011

China's CRO WuXi PharmaTech has announced its acquisition of research reagents manufacturer Abgent.

Read more 
Acino Acquires Cephalon’s Middle East & African Business for €80M

Acino Acquires Cephalon’s Middle East & African Business for €80M

17 Oct 2011

Acino said last week that it agreed to buy the Middle Eastern and African business of Cephalon for 60 million euros in cash and 20 million euros of new shares.

Read more 
CPHI China 2011 Interview: Ms. Li Fang, Manager of Trade Dept., Jiangsu Huanghe Medical Co., Ltd.

CPHI China 2011 Interview: Ms. Li Fang, Manager of Trade Dept., Jiangsu Huanghe Medical Co., Ltd.

14 Oct 2011

The CPhI, ICSE & BioPh China 2011 and P-MEC China 2011 were held in Shanghai from June 21, 2011 to June 23, 2011. During the exhibition, “CPhI-Online” had an interview with Ms. Li Fang, Manager of Trade Dept., Jiangsu Huanghe Medical Co., Ltd...

Read more 
CPHI China 2011 Interview: Ms. Cindy Zhao, President of J&K Group

CPHI China 2011 Interview: Ms. Cindy Zhao, President of J&K Group

14 Oct 2011

The CPhI, ICSE & BioPh China 2011 and P-MEC China 2011 were held in Shanghai from June 21, 2011 to June 23, 2011. During the exhibition, “CPhI-Online” had an interview with Ms. Cindy Zhao, President of J&K Group.

Read more